Updated ASH / ISTH Clinical Guidelines 2024
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.
Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.
Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.
Title: American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients
Authors: Paul Monagle, Muayad Azzam, Rachel Bercovitz, Marisol Betensky , Rukhmi Bhat, Tina Biss, Brian Branchford, Leonardo R. Brandão, Anthony K. C. Chan, E. Vincent S. Faustino, Julie Jaffray, Sophie Jones, Hassan Kawtharany, Bryce A. Kerlin, Nicole Kucine, Riten Kumar , Christoph Male , Marie-Claude Pelland-Marcotte, Leslie Raffini, Chittalsinh Raulji, Reem A. Mustafa.
See detailed information in Hemostasis Today.
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
-
Mar 17, 2026, 17:48Andrea Van Beek: Improving DOAC Adherence Saves Lives
-
Mar 17, 2026, 17:43Soumen Bhattacharyya: Microangiopathic Hemolytic Anemia Is Often a Hematologic Clue to Underlying Malignancy
-
Mar 17, 2026, 17:37Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
-
Mar 17, 2026, 17:31Armghan Ans: The 2026 Stroke Guidelines Are Excellent, Now the Hard Part
-
Mar 17, 2026, 17:26Danny Hsu: Navigating a Rebalanced Hemostatic State in Decompensated Cirrhosis
-
Mar 17, 2026, 17:21Matías J Alet on Acute Ischemic Stroke With Low NIHSS at NeuroQuality
-
Mar 17, 2026, 17:16S1PR4 Controls Platelet Fibrinogen Binding and Thrombus Formation – JTH
-
Mar 17, 2026, 15:55Mostafa Faisal Mohammed Saleh: Evidence-Based Recommendations for Hodgkin Lymphoma Management in LMICs